Non-Hodgkin lymphoma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Non-Hodgkin lymphoma may be classified into subtypes according to updated [[WHO]] classification and | Non-Hodgkin lymphoma may be classified into subtypes according to updated [[WHO]] classification and rate of growth. | ||
==Classification | ==Classification== | ||
===A. Updated WHO classification=== | ===A. Updated WHO classification=== | ||
* Non-Hodgkin lymphoma may be classified according to updated [[WHO]] classification into 2 groups:<ref name=”cancer gov”>National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/publications/pdq</ref> | * Non-Hodgkin lymphoma may be classified according to updated [[WHO]] classification into 2 groups:<ref name=”cancer gov”>National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/publications/pdq</ref> | ||
Line 29: | Line 29: | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[T-cell granular lymphocytic leukemia]] | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[T-cell granular lymphocytic leukemia]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Lymphoplasmacytic lymphoma / immunocytoma | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Mycosis fungoides]] / [[Sézary syndrome]] | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Mycosis fungoides]] / [[Sézary syndrome]] | ||
|- | |- | ||
Line 38: | Line 38: | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Hepatosplenic gamma / delta T-cell lymphoma | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Hepatosplenic gamma / delta T-cell lymphoma | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphatic tissue (MALT) type | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Subcutaneous panniculitis-like T-cell lymphoma]] | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Subcutaneous panniculitis-like T-cell lymphoma]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Nodal marginal zone B-cell lymphoma]] (± | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Nodal marginal zone B-cell lymphoma]] (± monocytoid B-cells) | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | Angioimmunoblastic T-cell lymphoma | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Splenic marginal zone lymphoma]] (± villous lymphocytes) | | style="padding: 5px 5px; background: #F5F5F5; text-align: center;" | [[Splenic marginal zone lymphoma]] (± villous lymphocytes) |
Revision as of 17:57, 2 October 2015
Non-Hodgkin lymphoma Microchapters |
Differentiating Non-Hodgkin's Lymphoma |
---|
Treatment |
Case Studies |
Non-Hodgkin lymphoma classification On the Web |
American Roentgen Ray Society Images of Non-Hodgkin lymphoma classification |
Risk calculators and risk factors for Non-Hodgkin lymphoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Non-Hodgkin lymphoma may be classified into subtypes according to updated WHO classification and rate of growth.
Classification
A. Updated WHO classification
- B-cell neoplasms
- T-cell and putative NK-cell neoplasms
B-cell neoplasms | T-cell and putative NK-cell neoplasms |
---|---|
Precursor B-cell neoplasm | Precursor T-cell neoplasm |
Precursor B-acute lymphoblastic leukemia / lymphoblastic lymphoma (LBL) | Precursor T-acute lymphoblastic leukemia / lymphoblastic lymphoma (LBL) |
Peripheral B-cell neoplasms | Peripheral T-cell and NK-cell neoplasms |
B-cell CLL / small lymphocytic lymphoma | T-cell CLL / prolymphocytic leukemia |
B-cell prolymphocytic leukemia | T-cell granular lymphocytic leukemia |
Lymphoplasmacytic lymphoma / immunocytoma | Mycosis fungoides / Sézary syndrome |
Mantle cell lymphoma | Peripheral T-cell lymphoma, not otherwise characterized |
Follicular lymphoma | Hepatosplenic gamma / delta T-cell lymphoma |
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphatic tissue (MALT) type | Subcutaneous panniculitis-like T-cell lymphoma |
Nodal marginal zone B-cell lymphoma (± monocytoid B-cells) | Angioimmunoblastic T-cell lymphoma |
Splenic marginal zone lymphoma (± villous lymphocytes) | Extranodal T-/NK-cell lymphoma, nasal type |
Hairy cell leukemia | Enteropathy-type intestinal T-cell lymphoma |
Plasmacytoma / plasma cell myeloma | Adult T-cell lymphoma / leukemia (human T-lymphotrophic virus [HTLV] 1+) |
Diffuse large B-cell lymphoma | Anaplastic large cell lymphoma, primary systemic type |
Burkitt lymphoma | Anaplastic large cell lymphoma, primary cutaneous type |
Aggressive NK-cell leukemia |
B. Classification based on rate of growth
- Non-Hodgkin lymphoma may be classified based on rate of growth into 2 Groups:[2]
- Low-grade or Indolent lymphoma
- High-grade or Aggressive lymphoma
Grade | Description |
---|---|
Low-grade or Indolent lymphoma |
|
High-grade or Aggressive lymphoma |
|
References
- ↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/publications/pdq
- ↑ "Canadian Cancer Society Grades of non-Hodgkin lymphoma".